Influence of Lung CT Changes in Chronic Obstructive Pulmonary Disease (COPD) on the Human Lung Microbiome

Background: Changes in microbial community composition in the lung of patients suffering from moderate to severe COPD have been well documented. However, knowledge about specific microbiome structures in the human lung associated with CT defined abnormalities is limited.

Methods: Bacterial community composition derived from brush samples from lungs of 16 patients suffering from different CT defined subtypes of COPD and 9 healthy subjects was analyzed using a cultivation independent barcoding approach applying 454-pyrosequencing of 16S rRNA gene fragment amplicons.

Results: We could show that bacterial community composition in patients with changes in CT (either airway or emphysema type changes, designated as severe subtypes) was different from community composition in lungs of patients without visible changes in CT as well as from healthy subjects (designated as mild COPD subtype and control group) (PC1, Padj = 0.002). Higher abundance of Prevotella in samples from patients with mild COPD subtype and from controls and of Streptococcus in the severe subtype cases mainly contributed to the separation of bacterial communities of subjects. No significant effects of treatment with inhaled glucocorticoids on bacterial community composition were detected within COPD cases with and without abnormalities in CT in PCoA. Co-occurrence analysis suggests the presence of networks of co-occurring bacteria. Four communities of positively correlated bacteria were revealed. The microbial communities can clearly be distinguished by their associations with the CT defined disease phenotype.

Conclusion: Our findings indicate that CT detectable structural changes in the lung of COPD patients, which we termed severe subtypes, are associated with alterations in bacterial communities, which may induce further changes in the interaction between microbes and host cells. This might result in a changed interplay with the host immune system.

Citing Articles

Exploring the Role of Gut-Lung Interactions in COPD Pathogenesis: A Comprehensive Review on Microbiota Characteristics and Inflammation Modulation.

Cheng Z, Zhang J Chronic Obstr Pulm Dis. 2024; 11(3):311-325.

PMID: 38563747 PMC: 11216226. DOI: 10.15326/jcopdf.2023.0442.

The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans.

Lin L, Yi X, Liu H, Meng R, Li S, Liu X Nat Med. 2023; 29(7):1750-1759.

PMID: 37349537 DOI: 10.1038/s41591-023-02424-2.

Respiratory microbiota and radiomics features in the stable COPD patients.

Wang R, Huang C, Yang W, Wang C, Wang P, Guo L Respir Res. 2023; 24(1):131.

PMID: 37173744 PMC: 10176953. DOI: 10.1186/s12931-023-02434-1.

Microbial dysbiosis and the host airway epithelial response: insights into HIV-associated COPD using multi'omics profiling.

Jude M, Xi Yang C, Filho F, Hernandez Cordero A, Yang J, Shaipanich T Respir Res. 2023; 24(1):124.

PMID: 37143066 PMC: 10161506. DOI: 10.1186/s12931-023-02431-4.

Gut microbiome composition associates with corticosteroid treatment, morbidity, and senescence in Chinook salmon (Oncorhynchus tshawytscha).

Couch C, Neal W, Herron C, Kent M, Schreck C, Peterson J Sci Rep. 2023; 13(1):2567.

PMID: 36782001 PMC: 9925776. DOI: 10.1038/s41598-023-29663-0.

References

Berenson C, Kruzel R, Wrona C, Mammen M, Sethi S . Impaired Innate COPD Alveolar Macrophage Responses and Toll-Like Receptor-9 Polymorphisms. PLoS One. 2015; 10(9):e0134209. PMC: 4567310. DOI: 10.1371/journal.pone.0134209. View

Lynch D, Al-Qaisi M . Quantitative computed tomography in chronic obstructive pulmonary disease. J Thorac Imaging. 2013; 28(5):284-90. PMC: 4161463. DOI: 10.1097/RTI.0b013e318298733c. View

Vogelmeier C, Criner G, Martinez F, Anzueto A, Barnes P, Bourbeau J . Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary. Respirology. 2017; 22(3):575-601. DOI: 10.1111/resp.13012. View

Tulek B, Kivrak A, Ozbek S, Kanat F, Suerdem M . Phenotyping of chronic obstructive pulmonary disease using the modified Bhalla scoring system for high-resolution computed tomography. Can Respir J. 2013; 20(2):91-6. PMC: 3630042. DOI: 10.1155/2013/727523. View

Juretschko S, Timmermann G, Schmid M, Schleifer K, Pommerening-Roser A, Koops H . Combined molecular and conventional analyses of nitrifying bacterium diversity in activated sludge: Nitrosococcus mobilis and Nitrospira-like bacteria as dominant populations. Appl Environ Microbiol. 1998; 64(8):3042-51. PMC: 106813. DOI: 10.1128/AEM.64.8.3042-3051.1998. View

Marti-Lliteras P, Regueiro V, Morey P, Hood D, Saus C, Sauleda J . Nontypeable Haemophilus influenzae clearance by alveolar macrophages is impaired by exposure to cigarette smoke. Infect Immun. 2009; 77(10):4232-42. PMC: 2747942. DOI: 10.1128/IAI.00305-09. View

Glassing A, Dowd S, Galandiuk S, Davis B, Chiodini R . Inherent bacterial DNA contamination of extraction and sequencing reagents may affect interpretation of microbiota in low bacterial biomass samples. Gut Pathog. 2016; 8:24. PMC: 4882852. DOI: 10.1186/s13099-016-0103-7. View

Rutten E, Grydeland T, Pillai S, Wagers S, Dirksen A, Coxson H . Quantitative CT: Associations between Emphysema, Airway Wall Thickness and Body Composition in COPD. Pulm Med. 2011; 2011:419328. PMC: 3100107. DOI: 10.1155/2011/419328. View

Dorn B, Leung K, Progulske-Fox A . Invasion of human oral epithelial cells by Prevotella intermedia. Infect Immun. 1998; 66(12):6054-7. PMC: 108773. DOI: 10.1128/IAI.66.12.6054-6057.1998. View

10.

Erb-Downward J, Thompson D, Han M, Freeman C, McCloskey L, Schmidt L . Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One. 2011; 6(2):e16384. PMC: 3043049. DOI: 10.1371/journal.pone.0016384. View

11.

Johnson M, Rennard S . Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD. Chest. 2001; 120(1):258-70. DOI: 10.1378/chest.120.1.258. View

12.

Larsen J, Musavian H, Butt T, Ingvorsen C, Thysen A, Brix S . Chronic obstructive pulmonary disease and asthma-associated Proteobacteria, but not commensal Prevotella spp., promote Toll-like receptor 2-independent lung inflammation and pathology. Immunology. 2014; 144(2):333-42. PMC: 4298427. DOI: 10.1111/imm.12376. View

13.

Ziegler-Heitbrock L, Frankenberger M, Heimbeck I, Burggraf D, Wjst M, Haussinger K . The EvA study: aims and strategy. Eur Respir J. 2012; 40(4):823-9. DOI: 10.1183/09031936.00142811. View

14.

Monso E, Ruiz J, Rosell A, Manterola J, Fiz J, Morera J . Bacterial infection in chronic obstructive pulmonary disease. A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med. 1995; 152(4 Pt 1):1316-20. DOI: 10.1164/ajrccm.152.4.7551388. View

15.

Servin A . Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol Rev. 2004; 28(4):405-40. DOI: 10.1016/j.femsre.2004.01.003. View

16.

Han Y, Shi W, Huang G, Haake S, Park N, Kuramitsu H . Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun. 2000; 68(6):3140-6. PMC: 97547. DOI: 10.1128/IAI.68.6.3140-3146.2000. View

17.

Schaffner A . Therapeutic concentrations of glucocorticoids suppress the antimicrobial activity of human macrophages without impairing their responsiveness to gamma interferon. J Clin Invest. 1985; 76(5):1755-64. PMC: 424202. DOI: 10.1172/JCI112166. View

18.

Schloss P, Westcott S, Ryabin T, Hall J, Hartmann M, Hollister E . Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009; 75(23):7537-41. PMC: 2786419. DOI: 10.1128/AEM.01541-09. View

19.

Ludwig W, Strunk O, Westram R, Richter L, Meier H, Yadhukumar . ARB: a software environment for sequence data. Nucleic Acids Res. 2004; 32(4):1363-71. PMC: 390282. DOI: 10.1093/nar/gkh293. View

20.

Ghosh A, Boucher R, Tarran R . Airway hydration and COPD. Cell Mol Life Sci. 2015; 72(19):3637-52. PMC: 4567929. DOI: 10.1007/s00018-015-1946-7. View